Warning: file_get_contents(http://tehnika-news.ru/shells.txt): failed to open stream: Connection refused in /var/sites/p/paperbomb.com/public_html/meds2/1/index.php on line 2
besponsa indication

besponsa indication

Перейти к контенту

Главное меню:

Разное
besponsa indication
Besponsa: Indications, Side Effects, Warnings - Drugs.com, Welcome to BESPONSA® | BESPONSA®, Besponsa - FDA prescribing information, side effects and uses, About BESPONSA® | BESPONSA®, BESPONSA™ (inotuzumab ozogamicin) | R/R B-Cell ALL , BESPONSA 1 mg powder for concentrate for solution for , Besponsa - Side Effects, Dosage, Interactions - Drugs , BESPONSA Dosage & Rx Info | Uses, Side Effects, BESPONSA - inotuzumab ozogamicin.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 May 2019), Cerner Multum™ (updated 2 May 2019), Wolters Kluwer™ (updated 1 May 2019) and others.. Warning Liver problems have happened with Besponsa (inotuzumab ozogamicin). Sometimes, this has been life-threatening or deadly. The chance of liver problems is higher in people who had a stem cell transplant after treatment with Besponsa (inotuzumab ozogamicin).. INDICATION. BESPONSA ® (inotuzumab ozogamicin) is a prescription medicine used to treat adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). It is not known if BESPONSA is safe and effective in children under 18 years of age. Please see Full Prescribing Information, including BOXED WARNING..
Besponsa is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). 2. DOSAGE AND ADMINISTRATION. indication BESPONSA ® (inotuzumab ozogamicin) is a prescription medicine used to treat adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). It is not known if BESPONSA is safe and effective in children under 18 years of age.. indication BESPONSA ® (inotuzumab ozogamicin) is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Please see full Prescribing Information , including BOXED WARNING.. BESPONSA 1 mg powder for concentrate for solution for infusion - Summary of Product Characteristics (SmPC) by Pfizer Limited Powder for concentrate for solution for infusion. White to off-white, lyophilised cake or powder. 4. Clinical particulars. 4.1 Therapeutic indications. BESPONSA is indicated as monotherapy for the treatment of adults with relapsed or refractory CD22-positive B cell . Inotuzumab ozogamicin is a monoclonal antibody linked to a chemotherapy drug. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy . BESPONSA prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects..
 
Copyright 2019. All rights reserved.
Назад к содержимому | Назад к главному меню